Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

ClinicalTrials.gov ID: NCT00394173

Public ClinicalTrials.gov record NCT00394173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 3:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of DNK333 25mg b.i.d. Given Orally for 4 Weeks in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of DNK333 compared to placebo for relieving symptoms of IBS-D in female patients.

Study identification

NCT ID
NCT00394173
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis
Industry
Enrollment
180 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2006 (Type not available)
Primary completion
Oct 2007 (Actual)
Completion
Oct 2007 (Actual)
Last update posted
Feb 27, 2017

2006 – 2007

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Investigative Site Tucson Arizona 85712 —
Investigative Site North Little Rock Arkansas 72114 —
Investigative Site Los Angeles California 90045-3119 —
Investigative Site Orange California 92869 —
Investigative Site Riverside California 92506 —
Investigative Site Sacramento California 95825 —
Investigative Site San Diego California 92108 —
Investigative Site Colorado Springs Colorado 80904 —
Investigative Site Bristol Connecticut 06010 —
Investigative Site Hartford Connecticut 06010 —
Investigative Site Boca Raton Florida 33486 —
Investigative Site Gainesville Florida 32256 —
Investigative Site Hollywood Florida 33021 —
Investigative Site Jacksonville Florida 782091744 —
Investigative Site Miami Florida 33173 —
Investigative Site New Smyrna Beach Florida 32168-7327 —
Investigative Site Tampa Florida 33607 —
Investigative Site Arlington Heights Illinois 60005 —
Investigative Site Rockford Illinois 61107 —
Investigative Site Boston Massachusetts 02215 —
Investigative Site Wellesley Hills Massachusetts 02481-2106 —
Investigative Site Mexico Missouri 65265-3726 —
Investigative Site Buffalo New York 14215 —
Investigative Site Great Neck New York 11023-2432 —
Investigative Site Elkin North Carolina 28621 —
Investigative Site Cincinnati Ohio 45219 —
Investigative Site Oklahoma City Oklahoma 73104 —
Investigative Site Portland Oregon 97220 —
Investigative Site Chattanooga Tennessee 37404 —
Investigative Site Lake Jackson Texas 77566 —
Investigative Site San Antonio Texas 78209-1744 —
Investigative Site Salt Lake City Utah 84102 —
Investigative Site Chesapeake Virginia 23320-1706 —
Investigative Site Bellevue Washington 98004 —
Investigative Site Everett Washington 98208 —
Investigative Site Monroe Washington 98208 —
Investigative Site Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00394173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2017 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00394173 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →